Timothy O. Falodun

Spironolactone reversed hepato-ovarian triglyceride accumulation caused by letrozole-induced polycystic ovarian syndrome: tissue uric acid—a familiar foe

O. Michael, O. Adeyanju, A. L. Oyewole, 2020, Naunyn-Schmiedeberg's Archives of Pharmacology.

Very low dose spironolactone protects experimentally-induced polycystic ovarian syndrome from insulin-resistant metabolic disturbances by suppressing elevated circulating testosterone.

O. Adeyanju, L. Olatunji, A. Soladoye, 2019, Chemico-biological interactions.

Safety and efficacy of pimecrolimus versus vehicle for the treatment of atopic dermatitis in adults and paediatric population: a systematic review and meta-analysis

A. Al-Hindawi, Talal Almas, Saifullah Syed, 2023, Annals of medicine and surgery.

Spironolactone reversed hepato-ovarian triglyceride accumulation caused by letrozole-induced polycystic ovarian syndrome: tissue uric acid—a familiar foe

O. Michael, O. Adeyanju, A. L. Oyewole, 2020, Naunyn-Schmiedeberg's Archives of Pharmacology.